Daniel Libke, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 385 Moraga Ave, Piedmont, CA 94611 Phone: 510-410-1545 |
News Archive
The long-standing prohibition against testosterone therapy in men with untreated or low-risk prostate cancer merits reevaluation, according to a new study published in The Journal of Urology.
The Affordable Care Act includes laws to help the public know the nutritional value of the food they buy. Consequently, larger chain restaurants will be required to indicate the calories count next to items on their menus. However, a study published yesterday suggests that this may not be the best way to encourage healthier eating habits.
A new study has linked exposure to two common perfluorinated chemicals (PFCs) with osteoarthritis. PFCs are used in more than 200 industrial processes and consumer products including certain stain- and water-resistant fabrics, grease-proof paper food containers, personal care products, and other items.
Babies born with Severe Combined Immune Deficiency (SCID) syndrome are defenceless against bacterial and viral infections that would be virtually harmless to most healthy people. If untreated, SCID is often fatal within a baby's first year of life.
Symphogen A/S, a private biopharmaceutical company developing recombinant antibody mixtures, a class of antibody therapeutics under investigation for the treatment or prophylaxis of serious human diseases such as cancer or infectious and autoimmune diseases, today announced that an exclusive worldwide license agreement was signed with Merck KGaA, Darmstadt, Germany, for Sym004, an investigational antibody mixture targeting the epidermal growth factor receptor (EGFR).
› Verified 8 days ago